TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolTSE:TOS
CUSIPN/A
Phone+1-418-6510003
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-34.69%
Return on Equity-48.85%
Return on Assets-28.90%
Miscellaneous
EmployeesN/A
Outstanding Shares92,891,000
TSO3 (TSE:TOS) Frequently Asked Questions
What is TSO3's stock symbol?
TSO3 trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TOS."
How were TSO3's earnings last quarter?
TSO3 Inc. (TSE:TOS) released its earnings results on Tuesday, May, 8th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The firm had revenue of $0.32 million for the quarter. TSO3 had a negative net margin of 34.69% and a negative return on equity of 48.85%. View TSO3's Earnings History.
When is TSO3's next earnings date?
What price target have analysts set for TOS?
5 brokerages have issued 12-month price targets for TSO3's stock. Their forecasts range from C$0.90 to C$2.75. On average, they anticipate TSO3's share price to reach C$1.73 in the next twelve months. View Analyst Ratings for TSO3.
Who are some of TSO3's key competitors?
Some companies that are related to TSO3 include TransEnterix (TRXC), CRH Medical (CRH), CRH Medical (CRHM), Tristel (TSTL), Clover (CLV), Bovie Medical (BVX), InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV) and Vigil Health Solutions (VGL).
Who are TSO3's key executives?
TSO3's management team includes the folowing people:
- Mr. Richard M. Rumble, Chief Exec. Officer, Pres and Director (Age 59)
- Mr. Glen Kayll, Chief Financial Officer (Age 49)
- Mr. Harold R. Tessman, Chief Operations Officer
- Mr. James Ralph Mills, VP of HR
- Mr. Anan Natarajan, Sr. VP of Global Commercialization
Has TSO3 been receiving favorable news coverage?
Media coverage about TOS stock has been trending somewhat positive this week, according to Accern. The research group rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. TSO3 earned a coverage optimism score of 0.09 on Accern's scale. They also gave media headlines about the company an impact score of 46.23 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of TSO3?
Shares of TOS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is TSO3's stock price today?
One share of TOS stock can currently be purchased for approximately C$1.05.
How big of a company is TSO3?
TSO3 has a market capitalization of C$105.96 million.
How can I contact TSO3?
TSO3's mailing address is 2505 Dalton Ave, QUEBEC, QC G1P 3S5, Canada. The company can be reached via phone at +1-418-6510003.
MarketBeat Community Rating for TSO3 (TOS)
MarketBeat's community ratings are surveys of what our community members think about TSO3 and other stocks. Vote "Outperform" if you believe TOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
